India’s drug regulator has flagged a batch of the widely used Abhayrab rabies vaccine as substandard and potentially spurious after a government laboratory found that it failed a potency test. The Drugs Controller General has asked state regulators to maintain strict vigilance over the distribution of batch KE25012 and take necessary regulatory action. The Central […]Continue Reading
